← Back to ADCT

ADC Therapeutics SA Common Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 04/05/2026Sep 2025Filed 10/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 04/05/2026Sep 2024Filed 10/11/2025Jun 2024Filed 12/08/2025Mar 2024Filed 14/05/2025
$19$20$16$18$17$18$17$18
−$17−$33−$41−$57−$39−$44−$37−$47
−$0.11−$0.21−$0.30−$0.50−$0.36−$0.42−$0.38−$0.56
1551541361141071059683

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.